Author:
Verburg Frederik A.,Giovanella Luca,Hoffmann Martha,Iakovou Ioannis,Mihailovic Jasna,Ovcaricek Petra Petranovic,Vrachimis Alexis,Luster Markus
Funder
University Hospital Marburg
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference15 articles.
1. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. JAMA. 1946;132:838–47.
2. Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, et al. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med. 2004;45:1366–72.
3. Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Görges R, et al. Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol. 2004;14:2092–8.
4. Anbar M, Guttmann S, Lewitus Z. Effect of monofluorosulphonate, difluorophosphate and fluoroborate ions on the iodine uptake of the thyroid gland. Nature. 1959;183:1517–8.
5. Entzian W, Aronow S, Soloway AHSW. A preliminary evaluation of F-18-labeled tetrafluoroborate as a scanning agent for intracranial tumors. J Nucl Med. 1964;5:542–50.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献